Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
Background: The SARS-CoV-2 virus causing COVID-19 binds human angiotensin-converting enzyme 2 (ACE2) receptors in human tissues. ACE2 expression may be associated with COVID-19 infection and mortality rates. Routinely prescribed drugs that up- or down-regulate ACE2 expression are, therefore, of crit...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-07-14
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.3399/bjgpopen20X101115 https://hdl.handle.net/20.500.12663/2073 |